ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 378 filers reported holding ENCOMPASS HEALTH CORP in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $217,000 | -30.4% | 3,335 | -19.7% | 0.00% | 0.0% |
Q3 2021 | $312,000 | -10.3% | 4,154 | -6.8% | 0.00% | 0.0% |
Q2 2021 | $348,000 | -4.9% | 4,457 | -0.2% | 0.00% | -20.0% |
Q1 2021 | $366,000 | -4.2% | 4,465 | -3.3% | 0.01% | -16.7% |
Q4 2020 | $382,000 | +12.0% | 4,619 | -12.1% | 0.01% | 0.0% |
Q3 2020 | $341,000 | -17.8% | 5,254 | -21.5% | 0.01% | -25.0% |
Q2 2020 | $415,000 | -29.7% | 6,697 | -27.3% | 0.01% | -42.9% |
Q1 2020 | $590,000 | -41.2% | 9,212 | -36.5% | 0.01% | -22.2% |
Q4 2019 | $1,004,000 | -4.8% | 14,500 | -13.1% | 0.02% | -14.3% |
Q3 2019 | $1,055,000 | -5.3% | 16,679 | -5.2% | 0.02% | -43.2% |
Q2 2019 | $1,114,000 | +1.0% | 17,586 | -6.9% | 0.04% | -15.9% |
Q1 2019 | $1,103,000 | -6.6% | 18,886 | -1.3% | 0.04% | -12.0% |
Q4 2018 | $1,181,000 | -28.3% | 19,136 | -9.5% | 0.05% | -13.8% |
Q3 2018 | $1,648,000 | +13.2% | 21,148 | -1.7% | 0.06% | +3.6% |
Q2 2018 | $1,456,000 | +15.7% | 21,507 | -2.3% | 0.06% | +16.7% |
Q1 2018 | $1,258,000 | – | 22,010 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |